The rate of myocardial adenosine uptake was studied in anesthetized openchest dogs to assess the importance of the process in the regulation of extracellular fluid concentrations of this coronary vasodilator. 8-14 C-adenosine solutions were infused into the left coronary artery at rates that yielded concentrations in coronary artery plasma of 0.4-13.3 yxM. The adenosine uptake rate was calculated as the product of the adenosine infusion rate and the extraction fraction of radioactivity assumed to be adenosine. Uptake appeared to follow Michaelis-Menten kinetics over the range of plasma adenosine concentrations tested, and the apparent values of K m and V mar were 11.6 ± 1.4 (SE) ^tM and 4.9 ± 0.5 (SE) nmoles/g left ventricle mirr 1 , respectively. The K m and the tissue activity of dog heart adenosine deaminase were 43 /AM and 1.2 /xmoles/g left ventricle min-1 , respectively, and those of adenosine kinase were 0.4 /JLM and 23 nmoles/g left ventricle min-1 , values sufficiently different from the parameters of uptake to suggest that the limiting step in uptake is permeation into the cell. Uptake was inhibited by 8-13 ^M 6-(pnitrobenzylthio)guanoside, an adenosine analogue that inhibits the facilitated diffusion of a variety of nucleosides in erythrocytes, and by dipyridamole, a compound that inhibits nucleoside uptake in erythrocytes, platelets, and tissue culture cells. Uptake was not inhibited by cardiotoxic doses of ouabain. These findings are evidence against uptake by simple diffusion but are consistent with uptake mediated by a carrier. The rate of cellular adenosine uptake from the extracellular space of the heart appears to be rapid enough to be important in the regulation of myocardial levels of this coronary vasodilator metabolite.
• Under certain circumstances, coronary vascular tone may be controlled by the myocardial concentration of adenosine (1) (2) (3) , but the factors regulating the concentration of adenosine to which the coronary arteries are exposed are incompletely understood. Because of the high intracellular activities of adenosinemetabolizing enzymes, the major adenosine pool of the heart is probably in the extracellular space (4) . Adenosine is not detectable in coronary venous plasma from oxygenated dog hearts (5) and the coronary arteriovenous adenosine difference is not significantly different from zero (6) , suggesting that adenosine washout from the extracellular space is probably not an important determinant of tissue levels and that other mechanisms such as adenosine uptake by the myocardial cells may be more important.
Jacob and Berne (7) and, more recently, Liu and Feinberg (8) showed that mammalian myocardium takes up exogenous adenosine and rapidly converts it to adenine nucleotides. However, these studies did not provide information identifying the mechanism of uptake in the heart. There is now abundant evidence that nucleosides are transported into a number of mammalian cells by a process of facilitated diffusion (9) (10) (11) (12) perhaps in combination with simple diffusion at high extracellular nucleoside levels (13, 14) . In a detailed model of adenosine metabolism in the heart, Schrader et al. (14) proposed that "at physiological concentrations, adenosine enters the myocardial cell by facilitated diffusion and the major fraction is directly phosphorylated to AMP by virtue of the fact that the K* of adenosine kinase is significantly lower than that of adenosine deaminase."
Facilitated diffusion has several characteristic features (15) . (1) The relation between the extracellular concentration of the substance being transported and its rate of uptake is not linear but is of the Michaelis-Menten type, i.e., transport is saturable. ( 2) The transport of a compound in one direction can be influenced by the movement of chemically similar compounds in the opposite directioncountertransport (3) Uptake of a compound can be competitively inhibited by another compound being transported concurrently in the same direction via a common carrier. (4) Substances which are not transported by the carrier can nonetheless combine with the carrier and thereby change the kinetics of transport.
The present study was undertaken to see whether the rate of adenosine uptake in canine heart is rapid enough to be important in the regulation of the levels of the nucleoside in the cardiac extracellular space and to obtain evidence about the type of process underlying myocardial adenosine uptake. The strategy followed to elucidate the mechanism of adenosine uptake was to compare the kinetic parameters of adenosine uptake in the blood-perfused heart of the openchest dog with the kinetic parameters of adenosine deaminase and adenosine kinase derived from canine left ventricular myocardium. The kinetic behavior of these enzymes was sufficiently different from the properties of uptake to suggest that the limiting step in uptake is permeation into the cell. Adenosine uptake appeared to follow Michaelis-Menten kinetics over the range of adenosine concentration which could be studied, and it was inhibited by both dipyridamole and 6-(pnitrobenzylthio) guanosine, an analogue of adenosine that inhibits the facilitated diffusion of nucleosides in erythrocytes (16) . Moreover, neither compound inhibited either adenosine kinase or adenosine deaminase in heart extracts, suggesting that the inhibitory effect of the drugs on adenosine uptake is probably exerted at the sarcolemmal membrane. Although these characteristics suggest that adenosine enters the myocardial cell by carriermediated transport rather than by simple diffusion, countertransport, which is perhaps the most convincing evidence for facilitated diffusion (17) , was not demonstrated. Finally, the estimated rate of adenosine uptake from the extracellular space by the myocardial cells appeared to be rapid enough to be important in regulating tissue levels of this metabolite.
Methods

MATERIALS
8-
14 C-adenosine and uniformly labeled adenosine were purchased from New England Nuclear and from Amersham/Searle Corporation, respectively. The compound 6-(p-nitrobenzylthio) guanosine (NBTGR) was prepared by alkylating 6-mercaptoguanosine with a-chloro-pnitrotoluene under conditions similar to those used for alleviation of the base (18) . This compound was obtained in nearly quantitative yield. Its melting point was 173.5-174.5°C (recxystallized from dimethylformamide-water solution). It migrated as a single spot on silica gel IB-F TLC plates (J. T. Baker Company) developed in a butanolwater-ammonia (84:16:5) solvent system, and its R-F value was equal to 0.51, compared with an R P value for 6-mercaptoguanosine-the starting material-of 0.11. The values of the extinction coefficient (eX 10-°) in 2.4* ethanol were: pH 1, undeterminable (shoulder) at 252 nm, 15.3 at 272 nm, and 15.8 at 318 nm; pH 7, 15.9 at 244 nm, undeterminable (shoulder) at 255 nm, and 17.8 at 308 nm; pH 13, undeterminable (shoulder) at 243 nm and 18.1 at 309 nm. 5'-Deoxyadenosine was synthesized by the method of McCarthy et al. (19) and was tritiated by catalytic exchange (New England Nuclear). The other unlabeled nucleosides and nucleotides used in this study were purchased from either Sigma Chemical Company or Calbiochem, and other analytic reagent-grade chemicals were purchased from various chemical supply houses. Ion-exchange celluloses were purchased from H. Reeve Angel and Company, Inc., and precoated silica gel and ion-exchange cellulose thin-layer chromatography plates were obtained from J. T. Baker Chemical Company.
ADENOSINE UPTAKE STUDIES
Beagles of either sex, weighing 12-16 kg, were anesthetized with sodium pentobarbital (approximately 30 mg/kg body weight, iv) and ventilated CitcmUia* Tleiurcb. Vol. XXXJ, Nottmker 1972 mechanically with a Harvard respirator pump via a cuffed endotracheal tube. The chest was opened through the left fourth intercostal space, the pericardium was opened, and a metal-tipped plastic catheter (20) was passed into the coronary sinus through the right atrium. The left coronary artery was cannulated with a Gregg cannula and perfused with blood from the left common carotid artery. Coronary blood flow rate was measured with a gated sine wave electromagnetic flowmeter interposed in the perfusion line, and perfusion pressure was monitored with a Statham P23Gb transducer connected to the perfusion line through a side arm. Catheters for blood sampling and drug administration were placed in the right atrium through the left external jugular vein and in the abdominal aorta through the right femoral artery. Heparin (200 mg, iv) was administered prior to coronary artery cannulation, and, if necessary, 100 mg was given every 30 minutes thereafter.
The rate of adenosine uptake was estimated by infusing a freshly prepared solution of 8-14 Cadenosine (approximately 2.5 mM, specific activity aproximately 1 mc/mmole) into the coronary perfusion line at a point immediately proximal to the Gregg cannula from a calibrated syringe at 5 or 6 rates ranging between 4 and 197 /^liters/ min. Coronary blood flow rate was held constant at the value which existed before infusion by adjusting a tunnel clamp on the perfusion line. Duplicate 1-ml samples of arterial and coronary venous blood were drawn 2 minutes after the beginning of each infusion period and quickly deproteinized in tared centrifuge tubes containing 2 ml of 6% (w/v) perchloric acid. Hematocrit was determined at the beginning and end of each experiment.
The effect of NBTGR on the rate of adenosine uptake was evaluated by infusing this compound into the coronary perfusion line at a rate calculated to give a concentration of 10 /XM in coronary plasma water. Five minutes after this infusion was started, an adenosine uptake experiment was carried out as described above, while the inhibitor infusion was continued. The effect of dipyridamole was evaluated similarly during an intracoronary infusion of this compound at a rate of 0.1 /mnole/min. Ouabain (0.2-0.25 mg, iv) was given every 5 minutes until ventricular premature contractions appeared, whereupon adenosine uptake was estimated as described above.
Samples, 2 ml each, of the perchloric acid-blood extract were pipetted into counting vials containing 13 ml of Bray's solution (21) , modified by the addition of butylated hydroxytoluene (1 g/liter) (Tenox, Eastman Chemical Products, Inc.). The vials were counted together with blanks and with Circulation Rmstircb, Vol. XXXI, Nmtmitr 1972 samples of the infusion solution of adenosine in a Picker Liquimat 220 liquid scintillation spectrometer.
Undoubtedly, there was some metabolism of adenosine by blood during the interval between its infusion into the coronary perfusion line and the time it reached the myocardial cells, which led to an underestimation of the concentration of adenosine to which the heart was exposed. To correct for the underestimation, 4.3, 10.9, or 15.2 nmoles of 8-14 C-adenosine were added with stirring to 1.67-ml samples of blood (hematocrit 41%) that had been freshly drawn from a heparinized dog and incubated at 37°C. After 10 seconds of incubation, 3.3 ml of ice-cold 65E perchloric acid was added, and the tubes were immediately shaken vigorously. Tubes containing 8-14 C-adenosine added to blood after deproteinization with perchloric acid were used as controls to correct for incomplete recovery of adenosine during subsequent processing.
The nucleosides contained in 4.0 ml of extract were separated on Dowex-50 columns (hydrogen ion form [12] ), the nucleoside-containing eluates were lyophilized, the residues were taken up in 0.2 ml of water, and 10-^liter samples were spotted on TLC plates of DEAE-cellulose. The plates were developed in 10 mM Tris-HCl, pH 8, and the spots corresponding to adenosine were cut out and placed in counting vials containing 15 ml of Aquasol (New England Nuclear) and 2 ml of water. The vials were counted, together with appropriate blanks and standards, in a Picker Liquimat 220 liquid scintillation spectrometer. Two experiments were done using blood from different dogs. All incubations were performed in duplicate.
We also measured the interval between the injection of T-1824 dye into the perfusion brie and the moment the surface of the heart was stained, and it ranged between 1.5 and 2 seconds. Assuming that adenosine is removed from the plasma at a constant rate under these conditions (22) and that 2 seconds is a reasonable figure for the duration of exposure of adenosine to blood prior to reaching the myocardium, the fraction of adenosine remaining at 2 seconds was estimated by interpolatiorL These data were then used to construct a curve for correcting adenosine concentration data.
COUNTERTRANSPORT OF AN ADENOSINE ANALOGUE
5'-Deoxyadenosine was chosen for countertransport studies because, lacking the 5'-hydroxyl function, it can be neither deaminated (23) nor phosphorylated. These studies were carried out using four dogs prepared as were those of the adenosine uptake studies. A 0.22 mM solution of tritiated 5'-deoxyadenosine (specific activity 22 mc/mmole) was infused into the coronary perfusion line at a rate of 0.2 ml/min for 7 minutes to load the cardiac muscle cells. Paired samples of arterial and coronary sinus blood were drawn immediately after the 5'-deoxyadenosine infusion was stopped and every minute thereafter for a total of 14 pairs of samples. After the fourth pair of samples was drawn, adenosine was infused into the coronary artery at a rate sufficient to give a calculated concentration in coronary plasma of 10 fxM, and this infusion was continued for 2-4 minutes. Thus, blood samples were obtained before, during, and after the adenosine infusion. These samples were deproteinized, and their radioactivity was determined as was that in the adenosine uptake studies.
ADENOSINE DEAMINASE AND ADENOSINE KINASE ASSAYS
Adenosine deaminase from canine left ventricle was purified by the method of Rockwell and Maguire (24) , and the K m of the enzyme thus prepared was determined as described in their report. The tissue activity of adenosine deaminase in canine left ventricle was determined in the supernatant fluid from high-speed centrifugation of the muscle homogenate. A portion of left ventricle was homogenized in three volumes of ice-cold 0.25M sucrose for 3 minutes in a Waring blendor, and this homogenate was then centrifuged at 30,000 g for 30 minutes at 0°C. Assays were carried out in duplicate in cuvettes containing 2.7 ml of 0.1M Tris-HCl, pH 7.5, 0.3 ml of 0.01M adenosine, 0.008 units of xanthine oxidase, and 0.125 units of nucleoside phosphorylase. After the contents of the cuvettes had equilibrated at 37 °C in a Gilford model 2000 absorbancy recorder fitted with a thermostatically controlled cell compartment, the assay was begun by adding 10, 20, or 50 //liters of the supernatant fluid obtained by high-speed centrifugation and recording the change in absorbance at 293 nm due to uric acid formation. Preliminary studies had established that both xanthine oxidase and purine nucleoside phosphorylase were present in excess, and this finding was confirmed by the fact that in the assays not only was the rate of uric acid formation proportional to the amount of supernatant fluid added, but also identical values for adenosine deaminase activity were obtained if xanthine oxidase and purine nucleoside phosphorylase were omitted and the rate of reaction calculated from the decrease in absorbancy at 262 nm.
Extracts of left ventricle for studies of adenosine kinase were prepared by homogenizing a portion of left ventricle for 1 minute with three volumes of ice-cold 2 HIM potassium phosphate, pH 7.0, containing 1 mM dithiothreitol (hereafter referred to as phosphate-DTT). All subsequent steps were carried out at 0-4°C. The homogenate was centrifuged for 30 minutes at 16,000 g, and the supernatant fluid from this centrifugation was centrifuged for 1 hour at 78,000 g. The supernatant fluid thus obtained was mixed with an equal volume of a DEAE-cellulose slurry prepared by suspending one volume of DEAEcellulose equilibrated in phosphate-DTT in four volumes of phosphate-DTT. The mixture of tissue extract and DEAE-cellulose was stirred in a ice bath for 2 hours and was then centrifuged for 5 minutes at 1,000 g. The supernatant fluid, diluted fiftyfold with phosphate-DTT, was used for adenosine kinase assays.
The reaction mixture for the kinetic studies of adenosine kinase consisted of 0 . 1 M potassium phosphate, pH 7.5, 2mM adenosine triphosphate (ATP), 0.5 mM MgCl 2 , 15 mM dithiothreitol, and 0.07-1.9 /AM uniformly labeled 14 C-adenosine (specific activity 566 mc/mmole) in a volume of 80 /uliters. Tubes containing this mixture were brought to 37 °C, and the reaction was started by adding 20 //.liters of heart extract. After 5 minutes, a 20-/Aliter sample of the reaction mixture was pipetted into 20 //liters of absolute ethanol, and this mixture was spotted on a TLC sheet of DEAE-cellulose together with a marker solution consisting of 20 nmoles each of adenosine monophosphate (AMP) adenosine, and inosine. The chromatograms were developed with 10 mM Tris-HCl, pH 8. In this system, inosine and hypoxanthine migrated as a single spot, and the R F values for AMP, inosine plus hypoxanthine, and adenosine were 0.03, 0.36, and 0.57, respectively. The plates were dried, and the spots corresponding to AMP, inosine plus hypoxanthine, and adenosine were cut out and placed in counting vials containing 15 ml of a solution of 4 g of 2,5-diphenyIoxazole (PPO) and 50 mg of l,4-fcis-2-(4-methyl-5-phenyloxazolyl)-benzene (dimethyl-POPOP) in 1 liter of toluene. The contents of the vials were counted, together with appropriate blanks and standards, in a Picker Liquimat 220 liquid scintillation spectrometer. Preliminary studies showed that AMP production was linear at this dilution of enzyme and this length of incubation and that less than 10* of the adenosine present in the reaction mixture was consumed.
The 78,000-g supernatant fluid not treated with DEAE-cellulose but diluted fourfold was used for estimates of the total tissue adenosine kinase activity of the left ventricle. The reaction mixture contained 5 mM reduced glutathione instead of dithiothreitol and 3-18 /AM adenosine, but the reaction conditions and procedures were otherwise the same.
The effect of NBTGR (10 /AM) and dipyridamole (5 /AM) on the rates of the kinase and deaminase Circulation Rtstarcb, Vol. XXXI, November 1972 reactions was studied in 78,000-g extracts containing both enzymes. The reaction mixture for these studies consisted of 2 fjusi adenosine, 2 HIM ATP, 0.5 mM MgCl 2 , 15 HIM dithiothreitol, and 100 mM potassium phosphate, pH 7, in a volume of 0.5 ml. At 5 and 30 minutes after the addition of heart extract, triplicate samples were deproteinized and spotted on DEAE-cellulose TLC plates, and the plates were chromatographed and counted as previously described.
CALCULATIONS
The putative concentration of adenosine in coronary plasma water during adenosine infussion, C, in moles/liter was calculated by the formula C = C ( XV CBFx (l-Hct) X0.92' (1) where C 4 = adenosine concentration of infusate (moles /liter), V = adenosine infusion rate (liters/min), CBF = coronary blood flow rate (liters/min), Hct = hematocrit (ml/100 ml), and 0.92 = plasma water content (liters water/liter plasma). This value was then corrected for metabolism of adenosine in blood during the interval between the injection of this nucleoside into the coronary perfusion line and the time at which it reached the exchange vessels of the heart by graphic interpolation from the adenosinedisappearance curve constructed as described above.
The rate of adenosine uptake by the left ventricle, v, in moles/g left ventricle min-1 was calculated by the formula
where CVR = corrected coronary venous radioactivity = coronary sinus radioactivity minus arterial blood radioactivity (dpm/ml), LVW = left ventricle weight (g), and A = activity of infusate (dpm/ml). Estimations of K m and V mal of adenosine uptake were made statistically by the method of Wilkinson (25) . The K, of dipyridamole and that of NBTGR for adenosine uptake were calculated by the method of Taube and Berlin (12) .
Results
The hemodynamic changes associated with the intracoronary administration of adenosine and the other compounds, alone or in combination, are shown in Table 1 . Infusion of adenosine at rates which gave concentrations in coronary plasma water of up to 13.3 /AM produced a slight decrease in heart rate and a sizable decrease in blood pressure. Infusions at still higher rates led to severe hypotension, bradycardia, and extremely variable estimates of adenosine uptake rate. The administration of the compounds tested for an effect on adenosine uptake rate produced minimal changes in heart rate and blood pressure. When adenosine was subsequently infused, its hemodynamic effects were directionally similar to and equal to or greater in magnitude than the effects of adenosine administered by itself except in the case of ouabain, which produced tachyarrhythrnias in two of the four dogs, so that the average heart rate in this group was increased.
The fractional rate of disappearance of adenosine added to the blood from two dogs in concentrations of 4.35, 10.9, and 15.2 /AM in plasma water was 14.7 ±2.43? ( S E ) , 17.1 ±2.8*. and 20.6 ± 3.6%, respectively, in 10 seconds. At these rates, the calculated amount of adenosine consumed in 2 seconds would be 2.9$, 3.7%, and 4.1$.
Hemodynamic Effects of Nucleosides and Drugs
The results of the studies of adenosine uptake are shown in Figure 1 . Over 80% of the adenosine infused was taken up by the heart at the lowest adenosine infusion rates, but extraction fell progressively as plasma concentrations were increased and was about 40% at plasma concentrations of 13.3 /AM. Preliminary experiments in two dogs showed that the amount of 14 C found in heart muscle samples at the end of adenosine infusions which gave adenosine concentrations of 3.3 and 7.8 /AM was 108 and 95%, respectively, of the values predicted by Eq. 2.
The rate of adenosine uptake appeared to increase as a hyperbolic function of the plasma adenosine concentration over the range studied. Plots of the reciprocal of uptake rate as a function of the reciprocal of plasma concentration were linear, and the coefficients of correlation for the individual experiments ranged between +0.995 and +0.999. The values of K m and Vm*i were calculated for each experiment, and the values for the four experiments were averaged giving a value for V mai of 4.9 ±0.5 (SE) nmoles/g left ventricle min-1 and a value for K m of 11.6±1.4 (SE) /XM.
Adenosine uptake was inhibited by the administration of NBTGR (K, 10 /AM) and dipyridamole (Ki 21 /AM), but ouabain had no effect on the rate of adenosine uptake.
COUNTERTRANSPORT OF AN ADENOSINE ANALOGUE
The rate of egress of 5'-deoxyadenosine from these hearts was very rapid, as evidenced by the rapid decrease in arteriovenous difference (tvi = 56 seconds). The rate of egress did not appear to be influenced by an infusion of adenosine.
PROPERTIES OF DOG HEART ADENOSINE DEAMINASE AND ADENOSINE KINASE
Partially purified adenosine deaminase from canine myocardium closely resembled the enzyme isolated from ox heart (24), had a K m of 43 /AM, and showed substrate inhibition at adenosine concentrations above 0.2 mM. Estimates of the tissue activity in six hearts gave an average value of 1.2±0.07 (SE) /unoles adenosine deaminated/g left ventricle min-1 at 37°C.
The adenosine kinase identified in the supernatant fluid of canine heart homogenates obtained by high-speed centrifugation and treated with DEAE-cellulose had a K m for adenosine of 0.4 /AM ( Fig. 2A) , which is somewhat lower than the values (1.8-5.6 /AM) reported for various tumor cells (26) (27) (28) or the value (0.9 /AM) reported for rat heart adenosine kinase (29) . Treatment of die homogenates with DEAE-cellulose removed about 70% of the adenosine kinase activity but 
Kinetics of canine cardiac adenosine kinase. A: Lineweaver-Burke plot of results using extract treated with DEAE-cellulose at ATP concentrations of 2mM (open circles) and 10 TTIM (solid circles). B. Estimate of total cardiac adenosine kinase activity. See text for details. V = rate of adenosine uptake; LV = left ventricle.
completely removed adenosine deaminase, as judged by spectrophotometric assays and also by a lack of conversion of 8-
14
C-adenosine to 8-1J C-inosine. DEAE-cellulose treatment did not result in any purification of the kinase, however, since the ratio of adenosine kinase activity to total protein in the extract remained unchanged. However, this treatment made it possible to estimate the K m of adenosine kinase substrate utilization free from the interference of adenosine deaminase. The optimum ATP concentration under these conditions of assay was 2 mM, and activity was competitively inhibited by 10 mM ATP, perhaps because of chelation of Mg 2+ , the concentration of which was 0.5 mM.
Extracts treated with DEAE-cellulose could not be used for estimating the tissue activity of adenosine kinase, because most of the enzyme was removed by this treatment. However, it was possible to adjust the dilution of the untreated tissue extract so that adenosine deaminase and adenosinetriphosphatase (ATPase) activities did not interfere too greatly with the measurement of the reaction Circileion Rtittrcb, Vol. XXXI, Nwm>if 1972 rates of adenosine kinase. Although as much as 40% of the adenosine was deaminated in 5 minutes, the reaction rates for adenosine kinase were linear between 0.5 and 5 minutes. The rates of AMP formation are minirnum estimations of the initial rate, and the substrate concentrations are maximum estimations (actual concentrations before the reaction was started). The direction of the errors in the estimations above makes possible a minimum estimation of the tissue activity of the enzyme by extrapolating to Vnmr in a double-reciprocal plot A value of 23 nmoles/g left ventricle min" 1 was found (Fig. 2B ).
Neither adenosine kinase nor adenosine deaminase was inhibited significantly by either dipyridamole or NBTGR in concentrations on the order of those used in the studies of adenosine uptake (Table 2) .
Discussion
There is no ideal choice of an experimental preparation for studies of the rate of myocardial adenosine uptake. Since the question asked in this study was whether the rate of adenosine uptake by the heart is fast enough to be important in regulating tissue levels, the most reliable answer would be obtained from blood-perfused hearts. However, metabolism of adenosine by the formed elements of blood subsequent to its infusion leads to an underestimation of the concentration to which the myocardial cells are exposed. Because the integrity of the cardiac cell membranes was the overriding consideration in this study, the hearts were perfused with the dog's own blood, and attempts were made to correct for losses due to metabolism. Accordingly, the concentration-dependent rate of disappearance of adenosine from freshly shed blood from a heparinized dog was measured, and these data were used to interpolate to 2 seconds, the estimated length of exposure of adenosine to blood prior to its reaching exchange vessels in these experiments.
As the experiments showed, the magnitude of the correction was not large, being less than 5% at adenosine concentrations of 15 /AM. This figure is much lower than the estimation made by Rubio et al. (5), who determined that the half-life of adenosine in dog blood is 10 seconds. The reason for the lower estimation in the present study may be a difference in experimental technique. Rubio and associates incubated blood for 10 seconds with adenosine at 37°C and then diluted and cooled the blood by adding two volumes of ice-cold saline. Adenosine was estimated in the plasma which separated during 15 minutes of centrifugation. Possibly, even though cooling and dilution slowed the rate of adenosine uptake, there was still substantial uptake during the time necessary to separate cells from plasma. In the present study, the blood specimens were deproteinized, and the fraction of adenosine remaining was estimated in the extract. The method of estimation employed in the present study exploits the recent demonstration that there is no adenosine pool in erythrocytes until extraordinarily high adenosine concentrations are reached (14) , so that the adenosine remaining in the extracts can be assigned to the plasma compartment with confidence.
The untoward hemodynamic effects of adenosine were a second obstacle to the estimation of the kinetics of uptake. Severe hypotension, bradycardia, and atrial asystole resulted from adenosine infusions yielding coronary plasma concentrations greater than 13.3 /XM. This concentration is approximately the same as the estimated K m of uptake, and, since accurate estimations of K m and V max require that the rate of uptake be studied at adenosine concentrations several times higher than K m , the present estimations of the kinetic parameters must be considered approximate.
It is possible that some of the adenosine which entered the heart was not phosphorylated but rather was degraded to inosine and hypoxanthine and then diffused out of the heart. We know of no way to design the experiment to account directly for this source of error. Since the rate of adenosine uptake Circulation Rtsurcb, Vol. XXXI, November 1972 was calculated from the corrected arteriovenous difference in radioactivity, any reentry of labeled degradation products into coronary venous blood would result in an underestimation of the true rate of adenostne uptake and, thereby, of Vmax.
The resultant of these effects would be an underestimation of the velocity of uptake at a given adenosine concentration. Since the main purpose of these estimations was to assess the importance of uptake in regulating extracellular adenosine levels, the direction of the errors will make a false affirmative answer unlikely.
The estimated K m of cardiac adenosine uptake, 11.6 /AM, is of the same order of magnitude as is the value of approximately 10 AIM found in other types of cells (10) (11) (12) (13) (14) , but it is higher than the values of 1 and 5 /AM found in Langendorff preparations of guinea pig and rat hearts, respectively (30) . Even though the kinetic parameters derived in this study may only apply to a limited range of adenosine concentrations, they are useful for predicting rates of adenosine uptake from the extracellular space of the heart under physiological conditions. Oxygenated heart contains about 0.3 nmoles adenosine/g left ventricle and about 2 nmoles/g left ventricle after 15 seconds of coronary occlusion (31). These levels correspond to concentrations of adenosine in the extracellular space of 1.5 and 10 /AM, respectively, which are within the range studied here (see below).
Hopkins and Goldie (30) showed that adenosine uptake in rat and guinea pig heart follows Michaelis-Menten kinetics, is temperature dependent, and, in the case of the guinea pig but not the rat, is blocked by dipyridamole. They also showed that dipyridamole, in concentrations which inhibit adenosine uptake, does not inhibit either the phosphorylation or the deamination of adenosine by guinea pig heart extracts. Alma and Feinberg (29) showed that dipyridamole does not inhibit adenosine ldnase from dog or rabbit heart. These results suggest that adenosine uptake in heart, as in other types of cells (10) (11) (12) (13) (14) , may occur via facilitated diffusion.
The evidence presented in this paper which give an average radius of 4.5 A, which is at least as large as the radii of sugars which are excluded by the myocardial cell membrane (33). (4) Adenosine uptake is not influenced by ouabain, a finding which tends to exclude sodium-dependent carrier-mediated uptake of the type responsible for the transport of certain sugars (34).
Although this study provides evidence consistent with carrier-mediated transport of adenosine, it was not possible to demonstrate countertransport of the nucleoside. In preliminary studies, hearts were treated first with 14 C-labeled adenosine and then with unlabeled adenosine in an attempt to elicit the efHux of 14 C-adenosine which would be expected if countertransport were occurring. These attempts were unsuccessful, presumably because of the rapid metabolism of adenosine subsequent to its entry into the myocardial cells and the very small intracellular adenosine pool available for exchange. To circumvent the problem of intracellular nucleoside metabolism, the hearts were loaded with 5'-deoxyadenosine, an analogue which can be neither phosphorylated nor deaminated, and were then exposed to adenosine. This attempt to demonstrate countertransport also failed.
Plagemann (13) found that adenosine uptake by tissue culture cells has the characteristics of facilitated diffusion below 50 /AM adenosine and those of simple diffusion above 100 /AM. A similar combination of uptake mechanisms was found in erythrocyte ghosts (14) . Because of the untoward hemodynamic effects of adenosine, it was possible to examine its uptake only over a relatively limited concentration range in the present study. Although carrier-mediated transport appeared to predominate, the coexistence of uptake by simple diffusion cannot be excluded.
The rates of adenosine uptake found in this study are suflBcient to constitute an important mechanism for the regulation of adenosine concentration in the extracellular space of the heart. Estimations of the adenosine content of oxygenated hearts give an average value of 0.3 nmoles/g left ventricle (31). The high intracellular levels of adenosine-metabolizing enzymes make it very likely that this adenosine pool is distributed mainly in the extracellular space (4), the volume of which is 0.2 ml/g left ventricle (33). The concentration to which the cell is exposed is, therefore, about 1.5 JUM. At this concentration, the rate of adenosine uptake, v, can be calculated by the Michaelis-Menten equation. (6) . Thus, the adenosine production rate of the oxygenated heart of the open-chest dog might be expected to be in the range of 0.6 to 0.9 nmoles/g left ventricle min- 1 . The kinetic parameters of adenosine deaminase and adenosine kinase determined in this study could also explain why adenosine taken up by the cell is preferentially phosphorylated rather than deaminated. Although this explanation does not exclude such a possibility, it obviates the necessity for postulating membrane-binding or compartmentalization of the kinase within the sarcoplasm (2, 10, 14) . Although the adenosine kinase activity of dog myocardium is very low relative to that of adenosine deaminase, its K m is a hundred times lower than that of the deaminase. The kinase thus competes for adenosine at an advantage at low substrate levels. The ratio of kinase activity to deaminase activity is given by the ratio of the Michaelis-Menten equations for each enzyme.
4.9 x 10-9 x 1.5 x 10-" A Q , , , a . . , . , v= , " " . , _v .. ," " =0.6 nmoles/g left ventricle mm" 1 .
(11.6+1.5) X 10-« This estimated rate, which, for the reasons given above, is probably an underestimation, is nevertheless sufficiently rapid to allow cellular uptake by itself to effect a complete turnover of the adenosine pool of the oxygenated heart twice per minute. Also, this figure may serve as a minimum estimation of the rate of production of adenosine. In a steady state, the size of the cardiac adenosine pool is constant and is the resultant of the rate of production and the sum of the rates of the various losses from the pool. This estimation is a minimum because, although it neglects the losses of adenosine by washout which appear to be very small (5) , it also fails to take into account the losses of inosine and hypoxanthine into the coronary venous blood. The total efflux of these compounds, which may be derived in part-although not necessarily v is the velocity of the reaction, V is the maximal velocity, K is the Michaelis constant, s is the substrate concentration, and the subscripts AK and AD refer to the kinase and the deaminase, respectively. At extremely low substrate concentrations (which are presumed to occur in the sarcoplasm), the value of s approaches zero, and the limiting value of this ratio then becomes up by the myocardial cells might be phosphorylated. Presumably the remainder is deaminated, but its ultimate fate, i.e., whether it is lost from the heart or enters the cardiac nucleotide pool via the purine salvage pathway (35), is unknown. This estimation, based on kinetic parameters obtained from in vitro studies of these enzymes, is in agreement with the experimental observations of others (7, 8) , which indicate that most of the adenosine taken up by the heart is found in the adenine nucleotide pool.
